Molecular Haematology
The Molecular Haematology team at Peter MacCallum Cancer Centre utilises a range of conventional and next generation sequencing-based technologies to improve outcomes of patients with haematological malignancies.
The Molecular Haematology team at Peter MacCallum Cancer Centre utilises a range of conventional and next generation sequencing-based technologies to improve outcomes of patients with haematological malignancies.
JAK2, CALR, MPL, SF3B1, KIT, CSF3R, ETNK1, SH2B3, ASXL1, CBL, EZH2, IDH1, IDH2, KRAS, NRAS, RUNX1, SETBP1, SRSF2, TET2, TP53, U2AF1, ZRSR2. $475 (non-MBS eligible) $357 (MBS item 73398) $612.10 (MBS item 73399) Preferred samples: 4 ml peripheral blood (EDTA) OR 1-2 ml bone marrow (EDTA) TAT: 28 days Methodology: Next Generation Sequencing (NGS)
Myeloproliferative Neoplasm (MPN) Gene Panel – 22 genes
ABL1, ARAF, ASXL1, BCL2, BIRC3, BRAF, BTK, CALR, CARD11, CBL, CD274, CD79B, CEBPA, CSF3R, CXCR4, DDX41*, DNMT3A, ETNK1, EZH2, FLT3**, FYN, GATA1, GATA2, ID3, IDH1, IDH2, IRF8, JAK2, JAK3, KIT, KRAS, MAP2K1, MPL, MYD88, NOTCH1, NPM1, NRAS, PDCD1LG2, PIGA, PFH6, PLCG1, PLCG2, RHOA, RUNX1, SETBP1, SF3B1, SH2B3, SRSF2, STAT3, STAT5B, STAT6, TCF3, TET2, TP53, U2AF1, XPO1, ZRSR2. *Excluded on request. **FLT3-ITD included when request $850 (non-MBS eligible) $653.65 (MBS item 73314) Preferred samples: 4 ml peripheral blood (EDTA); 1-2 ml bone marrow (EDTA); Tissue – fresh or FFPE block/slides (10 x 5 micron sections on positively charged slides) TAT: 28 days Methodology: Next Generation Sequencing (NGS)
Haematological Malignancy (ALLHAEM) Gene Panel – 57 genes
TP53 $475 (not MBS covered) Preferred samples: 4 ml peripheral blood (EDTA) 1-2 ml bone marrow (EDTA) Tissue – fresh or FFPE block/slides (10 x 5 micron sections on positively charged slides) TAT: 28 days Methodology: Next Generation Sequencing (NGS)
TP53 Gene Variant Analysis
$196.35 (non-MBS eligible) Fully covered (MBS item 73314) Preferred samples: 4 ml peripheral blood (EDTA) OR 1-2 ml bone marrow (EDTA) TAT: 7 days Methodology: Fragment analysis by capillary electrophoresis
FLT3-ITD & TKD
$196.35 (non-MBS eligible) Fully covered (MBS item 73314) Preferred samples: 4 ml peripheral blood (EDTA) OR 1-2 ml bone marrow (EDTA) TAT: 7 days Methodology: Fragment analysis by capillary electrophoresis
NPM1 (non-quantitative)
$196.35 (non-MBS eligible) Fully covered (MBS item 73314) Preferred samples: 20 ml peripheral blood (EDTA) OR 1-2 ml bone marrow (EDTA). Sample must be received within 72 hours of collection. TAT: 7 days Methodology: reverse transcription quantitative PCR (RT-qPCR)
BCR::ABL1
$196.35 (non-MBS eligible) Fully covered (MBS item 73314) Preferred samples: 20 ml peripheral blood (EDTA) OR 1-2 ml bone marrow (EDTA). Sample must be received within 72 hours of collection TAT: 14 days Methodology: reverse transcription quantitative PCR (RT-qPCR)
PML::RARA
$196.35 (non-MBS eligible) Fully covered (MBS item 73314) Preferred samples: 20 ml peripheral blood (EDTA) OR 1-2 ml bone marrow (EDTA). Sample must be received within 72 hours of collection. TAT: 14 days Methodology: reverse transcription quantitative PCR (RT-qPCR)
RUNX1::RUNX1T1
$196.35 (non-MBS eligible) Fully covered (MBS item 73314) Preferred samples: 20 ml peripheral blood (EDTA) OR 1-2 ml bone marrow (EDTA). Sample must be received within 72 hours of collection. TAT: 14 days Methodology: reverse transcription quantitative PCR (RT-qPCR)
CBFB::MYH11
Type A, B or D $196.35 (non-MBS eligible) Fully covered (MBS item 73314) Preferred samples: 20 ml peripheral blood (EDTA) OR 1-2 ml bone marrow (EDTA). Sample must be received within 72 hours of collection. TAT: 14 days Methodology: reverse transcription quantitative PCR (RT-qPCR)
NPM1 MRD
$129 (not MBS covered) Preferred samples: 4 ml (pre-transplant)/ 18 ml (post-transplant) peripheral blood (EDTA) OR 1-2 ml bone marrow (EDTA). Post-transplant samples must be received within 72 hours of collection. TAT: 14 days Methodology: Short tandem repeat (STR) fragment analysis by capillary electrophoresis
Chimerism Analysis
$400 (not MBS covered) Fully subsidised by Wilson Centre for Blood Cancer Genomics (if eligible – refer to request slip for eligibility criteria) Preferred samples: 4 ml peripheral blood (EDTA) OR 1-2 ml bone marrow (EDTA) TAT: 28 days
IGHV Somatic Hypermutation Analysis
$250 (not MBS covered) Preferred samples: 4 ml peripheral blood (EDTA) OR 1-2 ml bone marrow (EDTA) TAT: 28 days Methodology: Sanger sequencing
HAVCR2 Gene Variant Analysis
$250 (not MBS covered) Preferred samples: 4 ml peripheral blood (EDTA) OR 1-2 ml bone marrow (EDTA) TAT: 28 days Methodology: Sanger sequencing
UBA1 Gene Variant Analysis
$37.50
DNA Storage + Extraction